Click for best price
RadiopharmaceuticalsNuclear Medicine Market Size, Share 2024
| Market size in 2023 |
US$ 4531.6 million
|
Forecast Market size by 2030 |
US$ 6691.2 million
|
| Growth Rate |
CAGR of 5.3% |
Number of Pages |
163 Pages |
The global Radiopharmaceuticals in Nuclear Medicine market was valued at US$ 4531.6 million in 2023 and is projected to reach US$ 6691.2 million by 2030, at a CAGR of 5.3% during the forecast period.
This research report provides a comprehensive analysis of the Radiopharmaceuticals in Nuclear Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Radiopharmaceuticals in Nuclear Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Radiopharmaceuticals in Nuclear Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Radiopharmaceuticals in Nuclear Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Radiopharmaceuticals in Nuclear Medicine market presents opportunities for various stakeholders, including Diagnostic Application, Therapeutic Application. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Radiopharmaceuticals in Nuclear Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets.
The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Radiopharmaceuticals in Nuclear Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Radiopharmaceuticals in Nuclear Medicine market.
Market Overview: The report provides a comprehensive overview of the Radiopharmaceuticals in Nuclear Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Radiopharmaceuticals in Nuclear Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Radiopharmaceuticals in Nuclear Medicine market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Radiopharmaceuticals in Nuclear Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Radiopharmaceuticals in Nuclear Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Radiopharmaceuticals in Nuclear Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Radiopharmaceuticals in Nuclear Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Radiopharmaceuticals in Nuclear Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Radiopharmaceuticals in Nuclear Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Radiopharmaceuticals in Nuclear Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
Market segment by Application
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Other
Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Bracco Imaging S.P.A.
- Cambridge Isotope Laboratories, Inc.
- Cardinal Health, Inc.
- Covidien, Plc
- Eczacibasi-Monrol
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- IBA Group
- Isotec, Inc. (Sigma-Aldrich)
- Lantheus Medical Imaging, Inc.
- Nordion, Inc.
- Ntp Radioisotopes (Pty), Ltd.
- Siemens Healthcare (Subsidiary Of Siemens AG)
- Taiyo Nippon Sanso Corporation
- Urenco Limited
- Rotem Industries, Ltd., Inc.
- Australian Nuclear Association And Technology Organization (ANSTO)
- Board of Radiation And Isotope Technology (BRIT)
- Institute of Atomic Energy Polatom Radioisotope Centre
- Institute of Isotopes Co., Ltd.
- Institute Of Radioelement (IRE)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiopharmaceuticals in Nuclear Medicine, market overview.
Chapter 2: Global Radiopharmaceuticals in Nuclear Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Radiopharmaceuticals in Nuclear Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceuticals in Nuclear Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Radiopharmaceuticals in Nuclear Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Radiopharmaceuticals in Nuclear Medicine Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 4531.6 million
|
| Forecast Market size by 2030 |
US$ 6691.2 million
|
| Growth Rate |
CAGR of 5.3% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
163 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals in Nuclear Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals in Nuclear Medicine Overall Market Size
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size: 2023 VS 2030
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Radiopharmaceuticals in Nuclear Medicine Sales: 2019-2030
3 Company Landscape
3.1 Top Radiopharmaceuticals in Nuclear Medicine Players in Global Market
3.2 Top Global Radiopharmaceuticals in Nuclear Medicine Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Companies
3.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Companies
3.5 Global Radiopharmaceuticals in Nuclear Medicine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Radiopharmaceuticals in Nuclear Medicine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceuticals in Nuclear Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Market Size Markets, 2023 & 2030
4.1.2 Diagnostic Radiopharmaceuticals
4.1.3 Therapy Radiopharmaceuticals
4.1.4 Enriched Stable Isotopes
4.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2024
4.2.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2025-2030
4.2.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
4.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
4.3.1 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2024
4.3.2 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2025-2030
4.3.3 By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
4.4 By Type - Global Radiopharmaceuticals in Nuclear Medicine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2023 & 2030
5.1.2 Diagnostic Application
5.1.3 Therapeutic Application
5.1.4 Research
5.1.5 Pharmaceutical
5.1.6 Other
5.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2024
5.2.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2025-2030
5.2.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
5.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
5.3.1 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2024
5.3.2 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2025-2030
5.3.3 By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
5.4 By Application - Global Radiopharmaceuticals in Nuclear Medicine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Market Size, 2023 & 2030
6.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2024
6.2.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2025-2030
6.2.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
6.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales & Forecasts
6.3.1 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2024
6.3.2 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales, 2025-2030
6.3.3 By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.4.2 By Country - North America Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.4.3 US Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.4.4 Canada Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.4.5 Mexico Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.5.2 By Country - Europe Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.5.3 Germany Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.4 France Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.5 U.K. Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.6 Italy Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.7 Russia Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.8 Nordic Countries Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.5.9 Benelux Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.6.2 By Region - Asia Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.6.3 China Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.4 Japan Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.5 South Korea Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.6.7 India Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.7.2 By Country - South America Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.7.3 Brazil Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.7.4 Argentina Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales, 2019-2030
6.8.3 Turkey Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8.4 Israel Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8.5 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
6.8.6 UAE Radiopharmaceuticals in Nuclear Medicine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bracco Imaging S.P.A.
7.1.1 Bracco Imaging S.P.A. Company Summary
7.1.2 Bracco Imaging S.P.A. Business Overview
7.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.1.5 Bracco Imaging S.P.A. Key News & Latest Developments
7.2 Cambridge Isotope Laboratories, Inc.
7.2.1 Cambridge Isotope Laboratories, Inc. Company Summary
7.2.2 Cambridge Isotope Laboratories, Inc. Business Overview
7.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.2.5 Cambridge Isotope Laboratories, Inc. Key News & Latest Developments
7.3 Cardinal Health, Inc.
7.3.1 Cardinal Health, Inc. Company Summary
7.3.2 Cardinal Health, Inc. Business Overview
7.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.3.5 Cardinal Health, Inc. Key News & Latest Developments
7.4 Covidien, Plc
7.4.1 Covidien, Plc Company Summary
7.4.2 Covidien, Plc Business Overview
7.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.4.5 Covidien, Plc Key News & Latest Developments
7.5 Eczacibasi-Monrol
7.5.1 Eczacibasi-Monrol Company Summary
7.5.2 Eczacibasi-Monrol Business Overview
7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.5.5 Eczacibasi-Monrol Key News & Latest Developments
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation Company Summary
7.6.2 Fujifilm Holdings Corporation Business Overview
7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.6.5 Fujifilm Holdings Corporation Key News & Latest Developments
7.7 GE Healthcare (Subsidiary Of General Electric Company)
7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Summary
7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Key News & Latest Developments
7.8 IBA Group
7.8.1 IBA Group Company Summary
7.8.2 IBA Group Business Overview
7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.8.5 IBA Group Key News & Latest Developments
7.9 Isotec, Inc. (Sigma-Aldrich)
7.9.1 Isotec, Inc. (Sigma-Aldrich) Company Summary
7.9.2 Isotec, Inc. (Sigma-Aldrich) Business Overview
7.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.9.5 Isotec, Inc. (Sigma-Aldrich) Key News & Latest Developments
7.10 Lantheus Medical Imaging, Inc.
7.10.1 Lantheus Medical Imaging, Inc. Company Summary
7.10.2 Lantheus Medical Imaging, Inc. Business Overview
7.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.10.5 Lantheus Medical Imaging, Inc. Key News & Latest Developments
7.11 Nordion, Inc.
7.11.1 Nordion, Inc. Company Summary
7.11.2 Nordion, Inc. Business Overview
7.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.11.5 Nordion, Inc. Key News & Latest Developments
7.12 Ntp Radioisotopes (Pty), Ltd.
7.12.1 Ntp Radioisotopes (Pty), Ltd. Company Summary
7.12.2 Ntp Radioisotopes (Pty), Ltd. Business Overview
7.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.12.5 Ntp Radioisotopes (Pty), Ltd. Key News & Latest Developments
7.13 Siemens Healthcare (Subsidiary Of Siemens AG)
7.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Summary
7.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Business Overview
7.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Key News & Latest Developments
7.14 Taiyo Nippon Sanso Corporation
7.14.1 Taiyo Nippon Sanso Corporation Company Summary
7.14.2 Taiyo Nippon Sanso Corporation Business Overview
7.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.14.5 Taiyo Nippon Sanso Corporation Key News & Latest Developments
7.15 Urenco Limited
7.15.1 Urenco Limited Company Summary
7.15.2 Urenco Limited Business Overview
7.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.15.5 Urenco Limited Key News & Latest Developments
7.16 Rotem Industries, Ltd., Inc.
7.16.1 Rotem Industries, Ltd., Inc. Company Summary
7.16.2 Rotem Industries, Ltd., Inc. Business Overview
7.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.16.5 Rotem Industries, Ltd., Inc. Key News & Latest Developments
7.17 Australian Nuclear Association And Technology Organization (ANSTO)
7.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Company Summary
7.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Business Overview
7.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Key News & Latest Developments
7.18 Board of Radiation And Isotope Technology (BRIT)
7.18.1 Board of Radiation And Isotope Technology (BRIT) Company Summary
7.18.2 Board of Radiation And Isotope Technology (BRIT) Business Overview
7.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.18.5 Board of Radiation And Isotope Technology (BRIT) Key News & Latest Developments
7.19 Institute of Atomic Energy Polatom Radioisotope Centre
7.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Company Summary
7.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Business Overview
7.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Key News & Latest Developments
7.20 Institute of Isotopes Co., Ltd.
7.20.1 Institute of Isotopes Co., Ltd. Company Summary
7.20.2 Institute of Isotopes Co., Ltd. Business Overview
7.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.20.5 Institute of Isotopes Co., Ltd. Key News & Latest Developments
7.21 Institute Of Radioelement (IRE)
7.21.1 Institute Of Radioelement (IRE) Company Summary
7.21.2 Institute Of Radioelement (IRE) Business Overview
7.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Major Product Offerings
7.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales and Revenue in Global (2019-2024)
7.21.5 Institute Of Radioelement (IRE) Key News & Latest Developments
8 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity, Analysis
8.1 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity, 2019-2030
8.2 Radiopharmaceuticals in Nuclear Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceuticals in Nuclear Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiopharmaceuticals in Nuclear Medicine Supply Chain Analysis
10.1 Radiopharmaceuticals in Nuclear Medicine Industry Value Chain
10.2 Radiopharmaceuticals in Nuclear Medicine Upstream Market
10.3 Radiopharmaceuticals in Nuclear Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Radiopharmaceuticals in Nuclear Medicine in Global Market
Table 2. Top Radiopharmaceuticals in Nuclear Medicine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Companies, 2019-2024
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Sales by Companies, (K MT), 2019-2024
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 9. List of Global Tier 1 Radiopharmaceuticals in Nuclear Medicine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medicine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT), 2019-2024
Table 15. By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT), 2025-2030
Table 16. By Application ? Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT), 2019-2024
Table 20. By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT), 2025-2030
Table 21. By Region ? Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT), 2019-2024
Table 25. By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT), 2025-2030
Table 26. By Country - North America Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2019-2024
Table 29. By Country - North America Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2025-2030
Table 30. By Country - Europe Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2019-2024
Table 33. By Country - Europe Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2025-2030
Table 34. By Region - Asia Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2019-2024
Table 37. By Region - Asia Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2025-2030
Table 38. By Country - South America Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2019-2024
Table 41. By Country - South America Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2025-2030
Table 42. By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2019-2024
Table 45. By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales, (K MT), 2025-2030
Table 46. Bracco Imaging S.P.A. Company Summary
Table 47. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 48. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. Bracco Imaging S.P.A. Key News & Latest Developments
Table 50. Cambridge Isotope Laboratories, Inc. Company Summary
Table 51. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 52. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. Cambridge Isotope Laboratories, Inc. Key News & Latest Developments
Table 54. Cardinal Health, Inc. Company Summary
Table 55. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 56. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. Cardinal Health, Inc. Key News & Latest Developments
Table 58. Covidien, Plc Company Summary
Table 59. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 60. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. Covidien, Plc Key News & Latest Developments
Table 62. Eczacibasi-Monrol Company Summary
Table 63. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 64. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Eczacibasi-Monrol Key News & Latest Developments
Table 66. Fujifilm Holdings Corporation Company Summary
Table 67. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 68. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. Fujifilm Holdings Corporation Key News & Latest Developments
Table 70. GE Healthcare (Subsidiary Of General Electric Company) Company Summary
Table 71. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 72. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. GE Healthcare (Subsidiary Of General Electric Company) Key News & Latest Developments
Table 74. IBA Group Company Summary
Table 75. IBA Group Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 76. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. IBA Group Key News & Latest Developments
Table 78. Isotec, Inc. (Sigma-Aldrich) Company Summary
Table 79. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 80. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. Isotec, Inc. (Sigma-Aldrich) Key News & Latest Developments
Table 82. Lantheus Medical Imaging, Inc. Company Summary
Table 83. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 84. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. Lantheus Medical Imaging, Inc. Key News & Latest Developments
Table 86. Nordion, Inc. Company Summary
Table 87. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 88. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 89. Nordion, Inc. Key News & Latest Developments
Table 90. Ntp Radioisotopes (Pty), Ltd. Company Summary
Table 91. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 92. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 93. Ntp Radioisotopes (Pty), Ltd. Key News & Latest Developments
Table 94. Siemens Healthcare (Subsidiary Of Siemens AG) Company Summary
Table 95. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 96. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 97. Siemens Healthcare (Subsidiary Of Siemens AG) Key News & Latest Developments
Table 98. Taiyo Nippon Sanso Corporation Company Summary
Table 99. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 100. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 101. Taiyo Nippon Sanso Corporation Key News & Latest Developments
Table 102. Urenco Limited Company Summary
Table 103. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 104. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 105. Urenco Limited Key News & Latest Developments
Table 106. Rotem Industries, Ltd., Inc. Company Summary
Table 107. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 108. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 109. Rotem Industries, Ltd., Inc. Key News & Latest Developments
Table 110. Australian Nuclear Association And Technology Organization (ANSTO) Company Summary
Table 111. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 112. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 113. Australian Nuclear Association And Technology Organization (ANSTO) Key News & Latest Developments
Table 114. Board of Radiation And Isotope Technology (BRIT) Company Summary
Table 115. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 116. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 117. Board of Radiation And Isotope Technology (BRIT) Key News & Latest Developments
Table 118. Institute of Atomic Energy Polatom Radioisotope Centre Company Summary
Table 119. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 120. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 121. Institute of Atomic Energy Polatom Radioisotope Centre Key News & Latest Developments
Table 122. Institute of Isotopes Co., Ltd. Company Summary
Table 123. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 124. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 125. Institute of Isotopes Co., Ltd. Key News & Latest Developments
Table 126. Institute Of Radioelement (IRE) Company Summary
Table 127. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Offerings
Table 128. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 129. Institute Of Radioelement (IRE) Key News & Latest Developments
Table 130. Radiopharmaceuticals in Nuclear Medicine Production Capacity (K MT) of Key Manufacturers in Global Market, 2022-2024 (K MT)
Table 131. Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share of Key Manufacturers, 2022-2024
Table 132. Global Radiopharmaceuticals in Nuclear Medicine Production by Region, 2019-2024 (K MT)
Table 133. Global Radiopharmaceuticals in Nuclear Medicine Production by Region, 2025-2030 (K MT)
Table 134. Radiopharmaceuticals in Nuclear Medicine Market Opportunities & Trends in Global Market
Table 135. Radiopharmaceuticals in Nuclear Medicine Market Drivers in Global Market
Table 136. Radiopharmaceuticals in Nuclear Medicine Market Restraints in Global Market
Table 137. Radiopharmaceuticals in Nuclear Medicine Raw Materials
Table 138. Radiopharmaceuticals in Nuclear Medicine Raw Materials Suppliers in Global Market
Table 139. Typical Radiopharmaceuticals in Nuclear Medicine Downstream
Table 140. Radiopharmaceuticals in Nuclear Medicine Downstream Clients in Global Market
Table 141. Radiopharmaceuticals in Nuclear Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medicine Segment by Type in 2023
Figure 2. Radiopharmaceuticals in Nuclear Medicine Segment by Application in 2023
Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceuticals in Nuclear Medicine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue, 2019-2030 (US$, Mn)
Figure 7. Radiopharmaceuticals in Nuclear Medicine Sales in Global Market: 2019-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2023
Figure 9. By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 12. By Type - Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT), 2019-2030
Figure 13. By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 16. By Application - Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT), 2019-2030
Figure 17. By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 21. By Country - North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 23. US Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 28. Germany Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 29. France Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 37. China Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 41. India Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 44. Brazil Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share, 2019-2030
Figure 48. Turkey Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Radiopharmaceuticals in Nuclear Medicine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Radiopharmaceuticals in Nuclear Medicine Production Capacity (K MT), 2019-2030
Figure 53. The Percentage of Production Radiopharmaceuticals in Nuclear Medicine by Region, 2023 VS 2030
Figure 54. Radiopharmaceuticals in Nuclear Medicine Industry Value Chain
Figure 55. Marketing Channels
